Clinical Integration definition

Clinical Integration means a program of active and ongoing initiatives designed to evaluate and modify the practice patterns of, and create a high degree of interdependence and cooperation among, Network Providers, in order to improve the quality and efficiency of health care in the community, consistent with the relevant guidance and enforcement policies of the U.S. Department of Justice and the Federal Trade Commission.
Clinical Integration shall have the meaning set forth in the 1996 Joint Statements of Antitrust Enforcement Policy in Health Care by the Federal Trade Commission and U.S.
Clinical Integration means a network of health 5-28 care providers implementing an active and ongoing program to 5-29 evaluate and modify practice patterns by the network ’s participants 5-30 and create a high degree of independence and cooperation to control 5-31 costs and ensure quality.

Examples of Clinical Integration in a sentence

  • Practice, therefore, agrees that it and its Participating Physicians shall cooperate in the development and implementation of HMHP’s Clinical Integration program.

  • Practice and the Participating Physicians understand that Clinical Integration and the success of HMHP as a Clinically Integrated Network require Practice’s and the Participating Physicians’ active and ongoing participation.

  • At such time as HMHP implements its Clinical Integration program as a Clinically Integrated Network, HMHP may negotiate and enter into contracts with Payors that include all terms related to the delivery of Covered Services, including price and other terms related to payment (“CI Payor Contracts”).

  • As required by a Payor Contract and to ensure the success of the HMHP’s Clinical Integration program to achieve quality and cost efficiencies in the delivery of Covered Services, Practice and the Participating Physicians shall refer Enrollees, when medically appropriate, only to other HMHP Providers.

  • The Clinical Intensive experience is accompanied each semester by the Clinical Integration Seminar.

  • Clinical Integration of Next Generation Sequencing: Coverage and Reimbursement Challenges.

  • For the re-credentialing process, the Credentials Committee will review information received during the prior periods of participation, in accordance with the Peer Review Policy, and information relating to compliance with the Network Participation Agreement and the Clinical Integration Program.

  • Response: Please see Community and Clinical Integration Program (CCIP) under section F.

  • Community and Clinical Integration Program (CCIP) found on pages 42-43 of the RFP.

  • The Community and Clinical Integration Program (CCIP) states as a goal “introducing new care processes to reduce health equity gaps” (p.


More Definitions of Clinical Integration

Clinical Integration means a showing by the health care
Clinical Integration means a network of health 3-32 care providers implementing an active and ongoing program to 3-33 evaluate and modify practice patterns by the network ’s participants 3-34 and create a high degree of independence and cooperation to control 3-35 costs and ensure quality.
Clinical Integration means a health system that has demonstrated clinical leadership by taking accountability for delivering integrated clinical care delivery models for a defined population that are designed to produce quality, cost, efficiency and value.
Clinical Integration means a collaborative effort among providers and a central organizing system to implement clinical initiatives that control costs and improve quality, typically by strengthening coordination, standardizing clinical processes and protocols, and investing significantly in a centralized infrastructure.7
Clinical Integration means a program of active and ongoing initiatives designed to evaluate and modify the practice patterns of, and create a high degree of interdependence and cooperation among physicians affiliated with the Member, in order to improve the quality and efficiency of health care in the community, and may change in meaning as that term may be subsequently defined by relevant guidance and enforcement policy of the U.S. Department of Justice and the Federal Trade Commission.

Related to Clinical Integration

  • clinical investigation means any systematic investigation involving one or more human subjects, undertaken to assess the safety or performance of a device;

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Commercialization or “Commercialize” means any and all activities undertaken at any time for a particular Licensed Product and that relate to the manufacturing, marketing, promoting, distributing, importing or exporting for sale, offering for sale, and selling of the Licensed Product, and interacting with Regulatory Authorities regarding the foregoing.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Pre-Licensed Therapist means an individual who has obtained a Master’s Degree in Social Work or Marriage and Family Therapy and is registered with the BBS as an Associate CSW or MFT Intern acquiring hours for licensing. An individual’s registration is subject to regulations adopted by the BBS.

  • Software Product means any COTS which you propose to provide pursuant to the contract.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Clinical Study means a Xxxxx 0 Xxxxx, Xxxxx 2 Study, Phase 3 Study, Post-Marketing Study, Supplemental Study or other study (including a non-interventional study) in humans to obtain information regarding the product, including information relating to the safety, tolerability, pharmacological activity, pharmacokinetics, dose ranging or efficacy of the product.

  • Manufacturing Know-How means all information, techniques, inventions, discoveries, improvements, practices, methods, knowledge, skill, experience and other technology, whether or not patentable or copyrightable, and any copyrights based thereon, relating to or necessary or useful for the production, purification, packaging, storage and transportation of Collaboration Products, including without limitation specifications, acceptance criteria, manufacturing batch records, standard operating procedures, engineering plans, installation, operation and process qualification protocols for equipment, validation records, master files submitted to the FDA, process validation reports, environmental monitoring processes, test data including pharmacological, toxicological and clinical test data, cost data and employee training materials.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • SAP Technology Solution(s means SAP NetWeaver Foundation for Third Party Applications, SAP Cloud Platform (excluding when used solely as a Connectivity App between an SAP Application and S/4 EM) and SAP Leonardo IoT, Business Services (including any renamed, prior and/or successor versions of any of the foregoing made generally available by SAP if any, but excluding when any of the foregoing are used as a User Interface for S/4 EM).

  • Biomarker means a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. Biomarkers include, but are not limited to, gene mutations or protein expression.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Assistive technology device means any item, piece of equipment, or product system that is used to increase, maintain, or improve the functional capacities of a child with a disability.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • SDK means the JetBrains Rider Software Development Kit and specifically including any associated JetBrains Rider software files, documentation, software code or other materials made available by JetBrains and any third-party software programs that are owned and licensed by parties other than JetBrains and that are either integrated with or made part of the SDK (collectively, “Third-Party Software”).

  • Assistive technology means the devices, aids, controls, supplies, or appliances described in OAR 411-300-0150 that are purchased to provide support for a child and replace the need for direct interventions to enable self-direction of care and maximize independence of the child.